Some of today's most effective lung cancer treatments can cause rash, dry skin, or irritation around the nails. What if you could prepare before those side effects start? Patient host Jeanne Szurek talks with thoracic oncologist Dr. Olivia Fankuchen of Weill Cornell Medicine about proactive therapy management: what a simple prevention routine looks like, when to start it, what to watch for, and why speaking up about side effects can help you stay on the treatment that's working for you.

Guests:

Dr. Olivia Fankuchen – Thoracic medical oncologist, lung cancer specialist, and cancer researcher at Weill Cornell Medicine

Jeanne Szurek – Patient host and patient advocate, living with lung cancer

Learn more: Proactive Therapy Management - https://lcfamerica.org/living-with-lung-cancer/egfr-skin-side-effects/

Show Notes - https://lcfamerica.org/wp-content/uploads/2026/10/HWA-Fall-2026-Proactive-Therapy-Management-Show-Notes.pdf

Transcript - https://lcfamerica.org/wp-content/uploads/2026/10/HWA-Fall-2026-Proactive-Therapy-Management-Transcript.pdf

Watch Video - https://youtu.be/L-leRuQBtdo

Your oncologist says your IV treatment now comes as a SubQ injection. Is it really the same medicine? Will it hurt? Can you switch mid-treatment, and what if you want to switch back?

Patient host Jeanne Szurek, who switched from IV to SubQ herself, talks with Dr. Coral Olazagasti, assistant professor of thoracic oncology at Sylvester Comprehensive Cancer Center at the University of Miami. They go beyond the basics on what patients actually face once SubQ is on the table.

Topics discussed in this episode:

• Whether a SubQ injection works as well as an IV infusion • What a SubQ injection feels like, and where it's given • Which side effects change with SubQ, and which stay the same • Who may be eligible to switch mid-treatment • Insurance coverage, denials, and peer-to-peer review • How much clinic time SubQ can realistically give back • What to ask your oncologist about SubQ options • Where subcutaneous treatment research is heading

Learn more at LCFAmerica.org.

Guests: Dr. Coral Olazagasti (Sylvester Comprehensive Cancer Center, University of Miami) and Jeanne Szurek (LCFA patient host, living with lung cancer)

Show Notes: https://lcfamerica.org/wp-content/uploads/2026/09/HWA-Fall-2026-Switch-IV-to-SubQ-Show-Notes.pdf

Transcript: https://lcfamerica.org/wp-content/uploads/2026/09/HWA-Fall-2026-Switch-IV-to-SubQ-Transcript.pdf

Watch Video: https://youtu.be/A1-pkDfsHgM

Catch the conversation that started it all. Stephanie Williams and Dr. Olazagasti cover the fundamentals in What Is SubQ? How Subcutaneous Treatment Is Changing Life With Lung Cancer.

Small cell lung cancer has historically had few treatment options — but that's changing fast. In this episode, thoracic oncologist Dr. Ashish Saxena (Weill Cornell Medicine) joins host and SCLC survivor Wendy Brooks to discuss why asking about clinical trials early matters, how patient-reported outcomes are reshaping what "success" means in treatment, the newest immunotherapy and antibody drug conjugate approaches, and why speaking up about side effects helps both patients and future research. Visit lcfamerica.org to learn more.

Guests:

Dr. Ashish Saxena, MD, PhD — Chief of Thoracic Medical Oncology, Weill Cornell Medicine

Wendy Brooks, Voices of Hope Speakers Bureau member living with SCLC

Show Notes - https://lcfamerica.org/wp-content/uploads/2026/09/HWA-SCLC-Research-Innovation-Show-Notes.pdf

Transcript - https://lcfamerica.org/wp-content/uploads/2026/09/HWA-SCLC-Research-Innovation-Transcript.pdf

Watch Video - https://youtu.be/SYMHnFezSJI

Subscribe to Hope With Answers Living With Lung Cancer podcast for future episodes on your favorite listening platform. Apple Podcast | Spotify | Amazon Play | iHeart

Join LCFA's social media communities for support and information. Facebook | Twitter | Instagram | YouTube